Aranesp
List of products in the National Drug Code with proprietary name aranesp. This medication is used to treat anemia (low red blood cell count) in people with long-term serious kidney disease (chronic kidney failure) and people receiving chemotherapy for some types of cancer (cancer that does not involve the bone marrow or blood cells). Darbepoetin alfa also helps to reduce the need for blood transfusions. It works by signaling the bone marrow to make more red blood cells. This medication is very similar to the natural substance in your body (erythropoietin) that prevents anemia.
| NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Labeler Name | Product Type |
|---|---|---|---|---|---|---|
| 55513-002 | Aranesp | Darbepoetin Alfa | Solution | Intravenous; Subcutaneous | Amgen, Inc | Human Prescription Drug |
| 55513-003 | Aranesp | Darbepoetin Alfa | Solution | Intravenous; Subcutaneous | Amgen, Inc | Human Prescription Drug |
| 55513-004 | Aranesp | Darbepoetin Alfa | Solution | Intravenous; Subcutaneous | Amgen, Inc | Human Prescription Drug |
| 55513-005 | Aranesp | Darbepoetin Alfa | Solution | Intravenous; Subcutaneous | Amgen, Inc | Human Prescription Drug |
| 55513-006 | Aranesp | Darbepoetin Alfa | Solution | Intravenous; Subcutaneous | Amgen, Inc | Human Prescription Drug |
| 55513-021 | Aranesp | Darbepoetin Alfa | Injection, Solution | Intravenous; Subcutaneous | Amgen, Inc | Human Prescription Drug |
| 55513-023 | Aranesp | Darbepoetin Alfa | Injection, Solution | Intravenous; Subcutaneous | Amgen, Inc | Human Prescription Drug |
| 55513-025 | Aranesp | Darbepoetin Alfa | Injection, Solution | Intravenous; Subcutaneous | Amgen, Inc | Human Prescription Drug |
| 55513-027 | Aranesp | Darbepoetin Alfa | Injection, Solution | Intravenous; Subcutaneous | Amgen, Inc | Human Prescription Drug |
| 55513-028 | Aranesp | Darbepoetin Alfa | Injection, Solution | Intravenous; Subcutaneous | Amgen, Inc | Human Prescription Drug |
| 55513-032 | Aranesp | Darbepoetin Alfa | Injection, Solution | Intravenous; Subcutaneous | Amgen, Inc | Human Prescription Drug |
| 55513-057 | Aranesp | Darbepoetin Alfa | Injection, Solution | Intravenous; Subcutaneous | Amgen, Inc | Human Prescription Drug |
| 55513-098 | Aranesp | Darbepoetin Alfa | Injection, Solution | Intravenous; Subcutaneous | Amgen, Inc | Human Prescription Drug |
| 55513-111 | Aranesp | Darbepoetin Alfa | Injection, Solution | Intravenous; Subcutaneous | Amgen, Inc | Human Prescription Drug |
| 54868-5428 | Aranesp | Physicians Total Care, Inc. | ||||
| 54868-5429 | Aranesp | Physicians Total Care, Inc. | ||||
| 54868-5867 | Aranesp | Physicians Total Care, Inc. | ||||
| 55513-010 | Aranesp | Amgen Inc | ||||
| 55513-011 | Aranesp | Amgen Inc | ||||
| 55513-012 | Aranesp | Amgen Inc | ||||
| 55513-013 | Aranesp | Amgen Inc | ||||
| 55513-014 | Aranesp | Amgen Inc | ||||
| 55513-015 | Aranesp | Amgen Inc | ||||
| 55513-037 | Aranesp | Amgen Inc | ||||
| 55513-039 | Aranesp | Amgen Inc | ||||
| 55513-041 | Aranesp | Amgen Inc | ||||
| 55513-043 | Aranesp | Amgen Inc | ||||
| 55513-044 | Aranesp | Amgen Inc | ||||
| 55513-046 | Aranesp | Amgen Inc | ||||
| 55513-048 | Aranesp | Amgen Inc | ||||
| 55513-053 | Aranesp | Amgen Inc | ||||
| 55513-054 | Aranesp | Amgen Inc | ||||
| 55513-058 | Aranesp | Amgen Inc | ||||
| 55513-090 | Aranesp | Amgen Inc | ||||
| 55513-091 | Aranesp | Amgen Inc | ||||
| 55513-092 | Aranesp | Amgen Inc | ||||
| 55513-093 | Aranesp | Amgen Inc | ||||
| 55513-094 | Aranesp | Amgen Inc | ||||
| 55513-095 | Aranesp | Amgen Inc | ||||
| 55513-096 | Aranesp | Amgen Inc | ||||
| 55513-097 | Aranesp | Amgen Inc | ||||
| 55513-110 | Aranesp | Amgen Inc |